2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC4597
  



  

  
Submitter : 
  

  
Dr. Daniel Natali
  

  
Date & Time: 
  

  
12/27/2006 10:12:33
  



  

  
Organization : 
  

  
Affinity Medical Group
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Please issue guidelines to the pharmaceutical companies that when manufacturing vaccines, they restrict their use of stem cells to those lines established from sources other that fetal tissue obtained from aborted babies.

It only makes sense to utilize non-objectionable cell lines in vaccine production so that all people can benefit from them without compromising their moral belieefs and pro-life convictions.  Ethical sources are available.